A bstrae r o f: Biochemical and Bio physical Rcscarcb Comunications 267, 228-235 (2000) Previously, we isolated the human AE2 (SLC4A2) gene, a member of the sodium-independent anion exchanger family. Aat ortholog of this gene was reportad lo drive alternativa transcription yielding N-terminal variants of the AE2a message. We thus analyzed !he human AE2 gene in lhis regard. Using HepG2 cells, two alternativa first exons, each splicing to exon 3 in alternativa transcripts, were found lo be transcribed from overlapping sequences of intron 2. Exon 1 b1 corresponds lo the rat variant "b" and encondes three initial residues (MTQ) in AE2b1 isoform that replace the first 17 amino acids of AE2a protein, while the novel exon 1 b2 encodes eight initial residues (M DFLLRPQ) in AE2b2 isoform. The relativa abundance of AE2b1 and AE2b2 mANAs was about 10% of AE2a mANA each. Alternate prometer sequences have multiple potential binding motifs for liver-enriched factors, and dualluciferase assays ind icated that they possess the ability for driving transcription in transiently transfected HepG2 cells. Tissue suNey showed that expression of human AE2b 1 and AE2b2 transcripts is restricted to liver and kidney, while AE2a mANA was encountered in all examinad tissues. Our findings reveal a characteristic tissue-specific expression of two Nterminal variants of human AE2 from overlapping sequences In this study we have examinad intracellular cytokines in peripheral blood mononuclear cells (PBMC) of MS patients by flow cytometry (cytokine flow cytometry) . MS progressive patients showed an increased number of cells producing interferon-gamma (IFN-y) alter activation with phorbol 12-myristate 13-acetate and ionomycin, comparad with patients with clinically inactiva forms {P < 0001) and with healthy controls (P = 0001). These cells belonged to the CD4• and CDB' subsets in similar proportions. Clinically inactiva patients showed a lower level of cells producing IL-2 than controls (P = 0·03) and active MS patients (P = 0·03) . Most IL-2-producing cells were CD4 + lymphocytes, although a small part of the IL-2 was also produced by CDB+ cells. The percentage of cells producing simultaneously IL-2 and IFN-y was increased in active MS and they were mainly CD4' lymphocytes. No differences in !he production of IL-4 were observad between groups. However, we found an increased IL-1 O production in clinically active MS patients (P = 0·03). Treatment with IFN-P of active MS patients showed lower levels of cytokines when comparad with untreated MS patients. This methodological approach could help in the follow up and therapeutic monitoring of MS patients. Previous animal research and clinical experiences in humans suggest the existence of an auditory critical period in language acquisltion. We review the literature and present the changas withing the cochlear nuclei in bilaterally deafferentated adult nonhuman primates. We also present and analyse the results of 98 prelingually deaf children teenagers who underwent a cochlear implantation al the University of Navarra. Patients received a Nucleus 22 or 24 multichannel cochlear implant (CI). They were 1 5 grouped in five categories according lo their age at surgery. Performance is comparad with a control group of 58 postlinguals. Only early-implanted prelingual children (befare 6 years of age) achieved a complete open-set speech recognition, even with better performance than postlinguals. These results clearly demonstrate the existence of a period of high neural auditory plasticity within the first 6 years of lile. The introduction of auditory stimulation with a Cl can not restare the loss of neural plasticity out of this period. Prelingual children under 6 years of age should receive a Cl as soon as there is a reliable diagnosis of bilateral sensorineural hearing loss.
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